TKI258 dilactic acid is a protein tyrosine kinase inhibitor that has shown potent biochemical activity against FGFR. It targets c-Kit, FGFR1, c-Met, CSF-1R/c-Fms, EGFR, EphA2, FGFR3, FLT3, HER2, IGF-1R, and Insulin receptor.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.